Insider · CIK 0001368570

Wei Eric

Reports to the SEC for 2 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001368570

Forms 4 and 5

Insider transactions

42 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2017-02-07	LSTALISATA THERAPEUTICS, INC.S Sale	Director	SSale	−6,575 sh	$4.77	−$31.4K	172,223
2017-02-06	LSTALISATA THERAPEUTICS, INC.S Sale	Director	SSale	−500 sh	$4.75	−$2,375	178,798
2017-02-03	LSTALISATA THERAPEUTICS, INC.S Sale	Director	SSale	−1,525 sh	$4.76	−$7,256.255	179,298
2017-02-02	LSTALISATA THERAPEUTICS, INC.S Sale	Director	SSale	−5,000 sh	$4.51	−$22.5K	182,223
2017-02-02	LSTALISATA THERAPEUTICS, INC.S Sale	Director	SSale	−1,400 sh	$4.75	−$6,650.98	180,823
2017-01-09	LSTALISATA THERAPEUTICS, INC.A Award	Director	AAward	+1,650 sh	—	—	4,300
2017-01-09	LSTALISATA THERAPEUTICS, INC. · Options to Purchase Common StockA Award	Director	AAward	+2,750 sh	—	—	2,750
2016-11-21	LSTALISATA THERAPEUTICS, INC.S Sale	Director	SSale	−500 sh	$4.20	−$2,100	1,964,228
2016-07-01	LSTALISATA THERAPEUTICS, INC.S Sale	Director	SSale	−16.1K sh	$0.61	−$9,786.761	1,877,228
2016-06-30	LSTALISATA THERAPEUTICS, INC.S Sale	Director	SSale	−71.4K sh	$0.60	−$43K	1,893,322
2016-06-24	LSTALISATA THERAPEUTICS, INC.S Sale	Director	SSale	−15.3K sh	$0.55	−$8,421.6	1,964,728
2016-06-23	LSTALISATA THERAPEUTICS, INC.S Sale	Director	SSale	−7,386 sh	$0.55	−$4,062.3	1,980,040
2016-06-22	LSTALISATA THERAPEUTICS, INC.A Award	Director	AAward	+7,500 sh	—	—	26,500
2016-06-22	LSTALISATA THERAPEUTICS, INC. · Options to Purchase Common StockA Award	Director	AAward	+12.5K sh	—	—	12,500
2016-06-03	LSTALISATA THERAPEUTICS, INC.S Sale	Director	SSale	−16.6K sh	$0.55	−$9,103.6	2,045,686
2016-06-02	LSTALISATA THERAPEUTICS, INC.S Sale	Director	SSale	−60.8K sh	$0.55	−$33.4K	2,062,238
2016-03-06	LSTALISATA THERAPEUTICS, INC.S Sale	Director	SSale	−16.6K sh	$0.55	−$9,103.6	2,045,686
2016-02-06	LSTALISATA THERAPEUTICS, INC.S Sale	Director	SSale	−60.8K sh	$0.55	−$33.4K	2,062,238
2016-01-25	LSTALISATA THERAPEUTICS, INC.A Award	Director	AAward	+9,000 sh	—	—	19,000
2016-01-25	LSTALISATA THERAPEUTICS, INC. · Options to Purchase Common StockA Award	Director	AAward	+15K sh	—	—	15,000
2015-06-02	LSTALISATA THERAPEUTICS, INC.A Award	Director	AAward	+10K sh	—	—	2,132,988
2015-03-18	LSTALISATA THERAPEUTICS, INC.S Sale	Director	SSale	−100K sh	$3.20	−$320K	2,122,988
2015-01-02	LSTALISATA THERAPEUTICS, INC.A Award	Director	AAward	+12K sh	—	—	12,000
2015-01-02	LSTALISATA THERAPEUTICS, INC.G Gift	Director	GGift	+12K sh	—	—	2,222,988
2014-01-02	LSTALISATA THERAPEUTICS, INC.G Gift	Director	GGift	+12K sh	—	—	2,252,988
2014-01-02	LSTALISATA THERAPEUTICS, INC.A Award	Director	AAward	+12K sh	—	—	12,000
2013-12-09	LSTALISATA THERAPEUTICS, INC.S Sale	Director	SSale	−12.1K sh	$6.37	−$77.1K	2,240,988
2013-12-06	LSTALISATA THERAPEUTICS, INC.S Sale	Director	SSale	−434 sh	$6.35	−$2,755.9	2,253,084
2013-11-26	LSTALISATA THERAPEUTICS, INC.S Sale	Director	SSale	−10K sh	$6.26	−$62.6K	2,253,518
2013-01-04	LSTALISATA THERAPEUTICS, INC.G Gift	Director	GGift	+120K sh	—	—	22,665,180
2013-01-04	LSTALISATA THERAPEUTICS, INC.A Award	Director	AAward	+120K sh	—	—	120,000
2012-07-20	LSTALISATA THERAPEUTICS, INC.G Gift	Director	GGift	+15.3K sh	—	—	22,545,180
2012-06-29	LSTALISATA THERAPEUTICS, INC.A Award	Director	AAward	+15.3K sh	—	—	15,306
2012-01-12	LSTALISATA THERAPEUTICS, INC.G Gift	Director	GGift	+120K sh	—	—	22,529,874
2012-01-04	LSTALISATA THERAPEUTICS, INC.A Award	Director	AAward	+120K sh	—	—	120,000
2010-05-17	LSTALISATA THERAPEUTICS, INC.C Conversion	Director	CConversion	+9.09M sh	$0.90	+$8.18M	22,409,874
2010-05-17	LSTALISATA THERAPEUTICS, INC. · Series C Convertible Preferred StockC Conversion	Director	CConversion	−8.18M sh	—	—	0
2010-03-15	LSTALISATA THERAPEUTICS, INC.O Exercise Out-of-Money	Director	OExercise Out-of-Money	+1M sh	$1.75	+$1.75M	13,323,750
2010-03-15	LSTALISATA THERAPEUTICS, INC. · Common Stock Warrants (rights to buy)O Exercise Out-of-Money	Director	OExercise Out-of-Money	−1M sh	—	—	0
2010-02-18	LSTALISATA THERAPEUTICS, INC.G Gift	Director	GGift	+125K sh	—	—	11,583,009
2010-02-18	LSTALISATA THERAPEUTICS, INC.P Purchase	Director	PPurchase	+741K sh	$1.35	+$1M	12,323,750
2009-11-04	LSTALISATA THERAPEUTICS, INC. · Stock Options (right to buy)A Award	Director	AAward	+150K sh	—	—	150,000

Recent filings

Accepted (ET)
Feb 84
Caladrius Biosciences, Inc.0001144204-17-006741
SEC(opens sec.gov)
Feb 64
Caladrius Biosciences, Inc.0001144204-17-006290
SEC(opens sec.gov)
Jan 314
Caladrius Biosciences, Inc.0001144204-17-005185
SEC(opens sec.gov)
Nov 254
Caladrius Biosciences, Inc.0001144204-16-136487
SEC(opens sec.gov)
Jul 54
Caladrius Biosciences, Inc.0001144204-16-111512
SEC(opens sec.gov)
Jun 274
Caladrius Biosciences, Inc.0001144204-16-109998
SEC(opens sec.gov)
Jun 234
Caladrius Biosciences, Inc.0001144204-16-109554
SEC(opens sec.gov)
Jun 74/A
Caladrius Biosciences, Inc.0001144204-16-107350
SEC(opens sec.gov)
Jun 64
Caladrius Biosciences, Inc.0001144204-16-107135
SEC(opens sec.gov)
Jan 274
Caladrius Biosciences, Inc.0001144204-16-077394
SEC(opens sec.gov)

Companies

Address

C/O NEOSTEM, INC. 420 LEXINGTON AVENUE, SUITE 450

NEW YORK, NY, 10170